Acura Pharmaceuticals, Inc. (ACUR)
|Net Income (ttm)||-810,000|
|Trading Day||February 26|
|Day's Range||0.3500 - 0.3751|
|52-Week Range||0.12 - 0.45|
There are no news available yet.
Acura Pharmaceuticals, a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
In 2019, ACUR's revenue was $2.66 million, an increase of 548.05% compared to the previous year's $410,000. Losses were -$3.77 million, -1.77% less than in 2018.